References

1. Folstein M, Folstein S, McHugh P (1975) MINI-MENTAL STATE"A Practical Method for grading the Cognitive State of patients for the Clinican. J psychiat Res 12: 189-198 [CrossRef] [Google Scholar] [PubMed]
2. Coben L, Danzinger W, Storandt M (1985) A longitudinal EEG study of mild senile dementia of Alzheimer type. Electroencephalogr Clin Neurophysiol 61: 101-112 [CrossRef] [Google Scholar] [PubMed]
3. Soininen H, Partanen J, Laulumaa V, Pääkönen A, Helkala EL, et al. (1991) Serial EEG in Alzheimer´s disease: 3 year follow-up and outcome. Electroencephalogr Clin Neurophysiol 79: 342-348 [CrossRef] [Google Scholar] [PubMed]
4. Jelic V, Johansson SE, Almkvist O, Shigeta M, Julin P, et al. (2000) Quantitative electroencephalography in mild cognitive impairment: longitudinal changes and possible predictions of Alzheimer´s disease. Neurobiol Aging 21: 533-540 [CrossRef] [Google Scholar] [PubMed]
5. van der Hiele K, Bollen EL, Vein AA, Reijntjes RH, Westendorp RG, et al. (2008) EEG markers of future cognitive performance in the elderly. J Clin Neurophysiol 25: 83-89 [CrossRef] [Google Scholar] [PubMed]
6. Jeong J (2004) EEG dynamics in patients with Alzheimer´s disease. J Clin Neurophysiol 115: 1490-1505 [CrossRef] [Google Scholar] [PubMed]
7. Stigsby B, Johannesson G, Ingvar D (1981) Regional EEG analysis and regional cerebral blood flow in Alzheimer´s and Pick´s disease. Electroencephalogr Clin Neurophysiol 51: 537-547 [CrossRef] [Google Scholar] [PubMed]
8. Soininen H, Partanen V, Helkala EL, Riekkinen P (1982) EEG findings in senile dementia and normal aging. Acta Neurol Scand 65: 59-70 [CrossRef] [Google Scholar] [PubMed]
9. Pentillä M, Partanen V, Soininen H, Riekkinen P (1985) Quantitative analysis of Occipital EEG in different stages of Alzheimer´s disease. Electroencephalogr Clin Neurophysiol 60: 1-6 [CrossRef] [Google Scholar] [PubMed]
10. Brenner R, Ulrich R, Spiker D, Sclabassi R, Reynolds C, et al. (1986) Computerized spectral analysis in eldery normal, demented and depressed subjects Electroencephalogr Clin Neurophysiol 64: 483-492 [CrossRef] [Google Scholar] [PubMed]
11. Filipovic S, Gueguen B, Derouesne C, Ancri D, Bourdel MC, et al. (1989) Psychiatry Res 29: 409-410
12. Primavera A, Novello P, Finocchi C, Canevori E, Costello L, et al. (1990) Correlation between Mini-mental state examination and Quantitative electroencephalography in senile dementia of Alzheimer type. Neuropsychobiology 23: 74-78 [CrossRef] [Google Scholar] [PubMed]
13. Schreiter-Gasser U, Gasser T, Ziegler P (1993) Quantitative EEG analysis in early onset Alzheimer´s disease: a controlled study. Electroencephalogr Clin Neurophysiol 86: 15-22 [CrossRef] [Google Scholar] [PubMed]
14. Jelic V, Shigeta M, Julin P, Almkvist O, Winblad B, et al. (1996) Quantitative electroencephalography power and coherence in Alzheimer´s disease and mild cognitive impairment. Dement Geriatr Cogn Disord 7: 314-323 [CrossRef] [Google Scholar] [PubMed]
15. Ekedahl R (2019) Comparison of cholinergic status with quantitative EEG parameters in healthy subjects and patients suspected of dementia. Arch Biomed Eng Biotechnol 1: 3 [CrossRef] [Google Scholar]
16. Drachman D, Leavitt J (1974) Human memory and the cholinergic system. Arch Neurol 25: 113-121 [CrossRef] [Google Scholar] [PubMed]
17. Davies P (1976) Selective loss of central Cholinergic neurones in Alzheimer´s disease. Lancet 25: 1403 [CrossRef] [Google Scholar] [PubMed]
18. Perry E, Tomlinson B, Blessed G, Bergman K, Gibson P, et al. (1978) Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia. British medical Journal 2: 1457-1459 [CrossRef] [Google Scholar] [PubMed]
19. Bartus R, Dean R, Beer B, Lippa A (1982) The cholinergic hypothesis of geriatric memory dysfunction. Science 217: 408-417 [CrossRef] [Google Scholar] [PubMed]
20. Coyle J, Price D, DeLong M (1983) Alzheimer´s Disease: A Disorder of Cortical Cholinergic Innervation. Science 219: 1184-1190 [CrossRef] [Google Scholar] [PubMed]
21. Francis P, Palmer A, Sims N, Bowden D, Davison A, et al. (1985) Neurochemical studies of early-onset Alzheimer´s disease. N Engl J Med 313: 7-18 [CrossRef] [Google Scholar] [PubMed]
22. Frölich L (2002) The cholinergic pathology in Alzheimer´s diseasediscrepancies between clinical experience and pathophysiological findings. J Neural Transm 109: 1003-1014 [CrossRef] [Google Scholar] [PubMed]
23. Terry A, Buccafusco J (2003) The Cholinergic Hypothesis of Age and Alzheimer´s Disease-Related Cognitive Deficits: Recent Challenges and Their implications for Novel Drug Development. J Pharmacol Exp Ther 306: 821-827 [CrossRef] [Google Scholar] [PubMed]
24. Agnoli A, Martucci N, Manna V, Conti L, Fioravanti M, et al. (1983) Effect of Cholinergic and anticholinergic drugs on short term memory in Alzheimer´s dementia: a computerized Electroencephalographic study. Clin Neuropharmacol 6: 311-323 [CrossRef] [Google Scholar] [PubMed]
25. Sannita W, Maggio L, Rosadino G (1987) Effects of Scopolamine (0.25-0.75 mg i.m.) on the Quantitative EEG and the Neuropsychological status of healthy volunteers. Neuropsychobiology 17: 199-205 [CrossRef] [Google Scholar] [PubMed]
26. Riekkinen PJ, Riekkinen Jr PJ, Soininen H, Reinikainen KJ, Laulumaa V, et al. (1990) Regulation of EEG delta activity by the cholinergic nucleus basalis. In: Maurer K, Riederer P, Beckmann H, editors. Alzheimer’s Disease Epidemiology, Neuropathology, Neurochemistry, and Clinics Key Topics in Brain Research. Vienna: Springer
27. Alhainen K, Partanen J, Reiniainen K, Laulumaa V, Soininen H, et al. (1991) Discrimination of Tetrahydoaminoacridine responders by a single dose pharmaco-EEG in patients with Alzheimer´s disease. Neurosci Lett 127: 113- 116 [CrossRef] [Google Scholar] [PubMed]
28. Sloan E, Fenton G, Standage K (1992) Anticholinergic drug effects on quantitative Electroencephalogram, visual evoked potentials and verbal memory. Biol Psychiatry 31: 600-606 [CrossRef] [Google Scholar] [PubMed]
29. Neufeld M, Rabey M, Parmet Y, Sifris P, Treves T, et al. (1994) Effects of single intravenous dose of scopolamine on the quantitative EEG in Alzheimer´s disease patients and age-matched controls. Electroencephalogr Clin Neurophysiol 91: 407-412 [CrossRef] [Google Scholar] [PubMed]
30. Reeves R, Struve F, Patrick G (2002) The Effects of Donepezil on Quantitative EEG in Patients with Alzheimer´s Disease. Clin Electroencephalogr 33: 93-96 [CrossRef] [Google Scholar] [PubMed]
31. Hulstaert F, Blennow K, Ivanoiu A, Schoonderwaldt HC, Riemenschneider M, et al. (1999) Improved discrimination of AD patients using β-amyloid(1-42) and tau levels in CSF. Neurology 52: 1555-1562 [CrossRef] [Google Scholar] [PubMed]
32. Mehta PD, Pirttilä T, Mehta SP, Sersen EA, Aisen PS, et al. (2000) Plasma and Cerebrospinal Fluid Levels of Amyloid β1-40 and 1-42. Arch Neurol 57: 100-105 [CrossRef] [Google Scholar] [PubMed]
33. Mitchell A, Brindle N (2003) CSF phosphorylated tau-does it constitute an accurate biological test for Alzheimer`s disease? Int J Geriatr Psychiatry 18: 407-411 [CrossRef] [Google Scholar] [PubMed]
34. Hampel H, Teipel S, Fuschsberger T, Andreasen N, Wiltfang J, et al. (2004) Value of CSF β1-42 and tau as predictors of Alzheimer`s disease in patients with mild cognitive impairment. Mol Psychiatry 9: 705-710 [CrossRef] [Google Scholar] [PubMed]
35. Zetterberg H, Wahlund LO, Blennow K (2003) Cerbrospinal fluid markers for prediction of Alzheimer`s disease. Neurosciences Letters 352: 67-69 [CrossRef] [Google Scholar] [PubMed]
36. Herukka SK, HallikainenM, Soininen H, Pirtilla T (2005) CSF Ah42 and tau or phosphorylated tau and prediction of progressive mild cognitive impairment. Neurology 64: 1294-1297 [CrossRef] [Google Scholar] [PubMed]
37. Fagan A, Mintunen M, Mach R, Lee SY, Dence C, et al. (2006) Inverse relation between in vivo Amyloid imaging load and Cerebrospinal fluid Aβ42 in humans. Ann Neurol 59: 512-519 [CrossRef] [Google Scholar] [PubMed]
38. Hansson O, Zetterberg H, Buchhave P, Londos E, Blennow K, et al. (2006) Association between CSF biomarkers and incipient Alzheimer`s disease in patients with mild cognitive impairment: a follow-up study. Lancet Neurol 5: 228-234 [CrossRef] [Google Scholar] [PubMed]
39. Hampel H, Bürger K, Teipel SJ, Bokde AL, Zetterberg H, et al. (2008) Core candidate neurochemical and imaging biomarkers of Alzheimer`s disease. Alzheimers Dement 4: 35-45 [CrossRef] [Google Scholar] [PubMed]
40. Cavedo E, Lista S, Khachaturian Z, Aisen P, Amouyel P, et al. (2014) The Road Ahead to Cure Alzheimer`s Disease: Development of Biological Markers and Neuroimaging Methods for Prevention Trials Across all Stages and Target Populations. J Prev Alzheimer`s Dis 1: 181-202 [CrossRef] [Google Scholar] [PubMed]
41. Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, et al. (1999) Mild Cognitive Impairment Clinical Characterization and Outcom. Arch Neurol 56: 303-308 [CrossRef] [Google Scholar] [PubMed]
42. Niedermeyer E (2007) The normal EEG of the waking adult. In: Niedermeyer E, Silva FLd, editors. Electroencephalography. 5 ed. Philadelphia: Lippincott, Williams & Wilkins [Google Scholar]
43. Longo W (1966) Behavorial and Electroencephalographic effects of Atropine and related compounds. Pharmacol Rev 18: 971-974
44. Toledo JB, Xie SX, Trojanowski JQ, Shaw LM (2013) Longitudinal change in CSF Tau and Aβ biomarkers for up to 48 months in ADNI. Acta Neuropathol 126: 659-670 [CrossRef] [Google Scholar] [PubMed]
45. Palmqvist S, Mattsson N, Hansson O, Alzheimer’s Disease Neuroimaging Initiative (2016) Cerbrospinal fluid analysis detects cerebral amyloid-β accumulation earlier than positron emission tomography. Brain 139: 1226- 1236 [CrossRef] [Google Scholar] [PubMed]
46. Lobo A, Launer LJ, Fratiglioni L, Andersen K, Di Carlo A, et al. (2000) Prevalence of dementia and major subtypes in Europe: A collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group. Neurology 54: 4-9 [Google Scholar] [PubMed]